LONDON--Subsidiaries of pharmaceutical company Chiroscience Group here will provide bioinformatics support and other services to the biopharmaceutical company Geron, Menlo Park, Calif., under terms of an agreement announced earlier this month. The research collaboration will focus on diseases associated with the process of aging, capitalizing on the discovery by Chiroscience's Darwin Molecular of the gene for Werner's Syndrome, a condition that causes premature aging.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.